Experiment 437734
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | KAMPE,CE: LOWENBRAUN,S: FOSTER,J: ROSEN,G:. (1992). ORAL ETOPOSIDE IN TREATMENT OF ADVANCED REFRACTORY SARCOMAS.. 84(23) |
| Amount utilized | |
| Compound isolated | |
| Disease | 15 PATIENTS WITH DIAGNOSIS OF A CARCOMA WERE TREATED IN THIS STUDY WITH ETOPOSIDE FOR 15 CONSECUTIVE DAYS. 13 PATIENTS SHOWED PROGRESSIVE DISEASE AND 2 PATIENTS HAD STABLE DISEASE. MYELOSUPPRESSION WAS THE MOST FREQUENT TOXIC EFFECT EXPERIENCED BY PATIENTS. |
| Dose amount | 150.0 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |